Mark Strobeck - 01 Oct 2024 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Signature
/s/ Megan Timmins, Attorney-in-Fact for Mark Strobeck
Issuer symbol
RMTI
Transactions as of
01 Oct 2024
Net transactions value
-$7,971
Form type
4
Filing time
02 Oct 2024, 21:54:44 UTC
Previous filing
19 Mar 2024
Next filing
06 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMTI Common Stock Sale $7,971 -2,163 -1.4% $3.69 147,201 01 Oct 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024 in multiple trades at prices ranging from $3.67 to $3.69. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.